![]() |
|||
|
|
|
|
| UPDATE: July 1997 | MW: 695.74 | MF: C38H44N2O6•2Cl |
SYNONYMS:
|
|
| |
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
N/R
|
N/R
|
N/R
|
N/R
|
| |||
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intramuscular | mouse
lethal dose (50 percent kill): 540 µg/kg
|
N/R
|
KHFZAN 24(12),24,1990
|
intraperitoneal | mouse
lethal dose (50 percent kill): 420 µg/kg
|
N/R
|
RPTOAN 32,74,1969
|
intraperitoneal | rat
lethal dose (50 percent kill): 340 µg/kg
|
Behavioral: Muscle weakness | Lung, Thorax, or Respiration: Respiratory depression Lung, Thorax, or Respiration: Other changes
OYYAA2 9,117,1975
|
intravenous | guinea pig
lethal dose (50 percent kill): 66 µg/kg
|
Behavioral: Convulsions or effect on seizure threshold | Lung, Thorax, or Respiration: Other changes
JLCMAK 34,516,1949
|
intravenous | mouse
lethal dose (50 percent kill): 97 µg/kg
|
N/R
|
AIPTAK 109,191,1957
|
intravenous | rat
lethal dose (50 percent kill): 66 µg/kg
|
Behavioral: Muscle weakness | Lung, Thorax, or Respiration: Respiratory depression Lung, Thorax, or Respiration: Other changes
OYYAA2 9,117,1975
|
intravenous | rabbit
lethal dose (50 percent kill): 170 µg/kg
|
N/R
|
KHFZAN 24(12),24,1990
|
oral | mouse
lethal dose (50 percent kill): 33 mg/kg
|
N/R
|
PSEBAA 120,511,1965
|
oral | rat
lethal dose (50 percent kill): 28 mg/kg
|
N/R
|
PSEBAA 120,511,1965
|
subcutaneous | mouse
lethal dose (50 percent kill): 640 µg/kg
|
Behavioral: Muscle weakness | Lung, Thorax, or Respiration: Respiratory depression Lung, Thorax, or Respiration: Other changes
OYYAA2 9,117,1975
|
subcutaneous | rat
lethal dose (50 percent kill): 310 µg/kg
|
Behavioral: Muscle weakness | Lung, Thorax, or Respiration: Respiratory depression Lung, Thorax, or Respiration: Other changes
OYYAA2 9,117,1975
|
| |||
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
N/R
|
N/R
|
N/R
|
| ||
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
N/R
|
N/R
|
N/R
|
| ||
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: X5569 |
Number of Industries 1; Total Number of Facilities 34; Number of Occupations 3; Total Number of Employees Exposed 1,010; Total Number of Female Employees Exposed 668 | |||
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
EPA GENETOX PROGRAM 1988, Inconclusive: E coli polA without S9; Histidine reversion-Ames test
|
| ||
REFERENCES:
CODEN
|
|
REFERENCE
AIPTAK
|
Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of
Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898-
|
JLCMAK
|
Journal of Laboratory and Clinical Medicine. (C.V. Mosby Co., 11830 Westline Industrial Dr.,
St. Louis, MO 63141) V.1- 1915-
|
KHFZAN
|
Khimiko-Farmatsevticheskii Zhurnal. Chemical Pharmaceutical Journal. For English
translation, see PCJOAU. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1967-
|
OYYAA2
|
Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1-
1967-
|
PSEBAA
|
Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E.
First St., Duluth, MN 55802) V.1- 1903/04-
|
RPTOAN
|
Russian Pharmacology and Toxicology (English Translation). Translation of FATOAO. (Euromed
Pub., 33, Woodlands Rd., Surbiton, Surrey, UK) V.30- 1967-
|
| |